FDA Approves Risperdal
Risperdal Approved for for Schizophrenia, Bipolar Mania
Risperdal is a psychotropic agent indicated for the treatment of schizophrenia, and for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder.Related Articles:
FDA Issues Complete Response Letter for Risperdal Consta for the Adjunctive Maintenance Treatment of Bipolar Disorder - February 11, 2009
FDA Approves New Injection Site for Risperdal Consta for Schizophrenia Treatment - October 10, 2008
Supplemental New Drug Application for Risperdal Consta Submitted to the FDA for the Treatment of Bipolar Disorder - July 24, 2008
Supplemental New Drug Application for Risperdal Consta Submitted to the FDA for the Treatment of Frequently Relapsing Bipolar Disorder - April 14, 2008
FDA Approves Risperdal to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania - August 22, 2007
FDA Issues Approvable Letter for Risperdal to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania - June 21, 2007
FDA Approves New Dose of Risperdal Consta for Schizophrenia Treatment - April 13, 2007
FDA Approves Risperdal to Treat Irritability Associated with Autism - October 6, 2006
Risperdal Consta Approved for Schizophrenia - October 29, 2003
FDA Drug Approvals Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Aug | Oct | Dec
